149:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
10.  Esu E, Effa EE, Opie ON, :@0.076190:0.082219:0.254202:0.082219:0.254202:0.069944:0.076190:0.069944:0.006515:0.006515:0.003257:0.003257:0.005656:0.006303:0.004563:0.007150:0.006797:0.006303:0.003257:0.006797:0.006303:0.003692:0.003692:0.008032:0.006797:0.006303:0.006303:0.003257:0.006797:0.010219:0.008020:0.002352:0.007644:0.006797:0.010219:0.008702:0.003257:0.003257
et al.:@0.257741:0.082219:0.289809:0.082219:0.289809:0.069944:0.257741:0.069944:0.007644:0.003986:0.006797:0.008032:0.002352:0.003257
 Artemether  for  severe malaria. :@0.289809:0.082219:0.484213:0.082219:0.484213:0.069944:0.289809:0.069944:0.006797:0.008702:0.003540:0.003986:0.007644:0.011030:0.007644:0.003986:0.007173:0.007644:0.003540:0.003257:0.003516:0.003692:0.007702:0.003540:0.003257:0.003528:0.004563:0.007644:0.006515:0.007644:0.003540:0.007644:0.006797:0.011030:0.008032:0.002352:0.008032:0.003540:0.002352:0.008032:0.003257:0.003257
Cochrane Database syst Rev. 2014;(9):CD010678:@0.101390:0.093121:0.380332:0.093121:0.380332:0.080845:0.101390:0.080845:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515
11.  Maitland K, Kiguli s, Opoka RO, :@0.076190:0.104022:0.279625:0.104022:0.279625:0.091747:0.076190:0.091747:0.006515:0.006515:0.003257:0.003257:0.005656:0.010807:0.008032:0.002352:0.003986:0.002352:0.008032:0.007173:0.008055:0.003069:0.006950:0.003257:0.003057:0.006950:0.002352:0.007914:0.007150:0.002352:0.002352:0.003069:0.005856:0.003257:0.003057:0.010219:0.008020:0.007702:0.005903:0.008032:0.003057:0.007138:0.010219:0.003257:0.003257
et al.:@0.279437:0.104022:0.307765:0.104022:0.307765:0.091747:0.279437:0.091747:0.007644:0.003986:0.003057:0.008032:0.002352:0.003257
 Mortality after fluid bolus in Af:@0.307765:0.104022:0.477040:0.104022:0.477040:0.091747:0.307765:0.091747:0.003057:0.010807:0.007702:0.003540:0.003986:0.008032:0.002352:0.002352:0.003986:0.006303:0.003057:0.008032:0.003692:0.003986:0.007644:0.003540:0.003057:0.002852:0.002852:0.007150:0.002352:0.008055:0.003057:0.008020:0.007702:0.002352:0.007150:0.004563:0.003069:0.002352:0.007173:0.003057:0.008702:0.003692
-:@0.477040:0.104022:0.480944:0.104022:0.480944:0.091747:0.477040:0.091747:0.003904
rican children with severe infection. :@0.101390:0.114924:0.305531:0.114924:0.305531:0.102648:0.101390:0.102648:0.003540:0.002352:0.007608:0.008032:0.007173:0.003128:0.007608:0.007173:0.002352:0.002352:0.008055:0.003540:0.007644:0.007173:0.003128:0.009772:0.002352:0.003986:0.007173:0.003128:0.004563:0.007644:0.006515:0.007644:0.003540:0.007644:0.003128:0.002352:0.007173:0.003692:0.007644:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
N Engl J Med.:@0.305413:0.114924:0.382672:0.114924:0.382672:0.102648:0.305413:0.102648:0.008702:0.003128:0.006303:0.007173:0.007914:0.002352:0.003128:0.005668:0.003128:0.010807:0.007644:0.008055:0.003257
 2011;364:2483-95:@0.382672:0.114924:0.480909:0.114924:0.480909:0.102648:0.382672:0.102648:0.003128:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515
12.  Church J, Maitland K. Invasive  bacterial co-infection in African :@0.076190:0.125825:0.484213:0.125825:0.484213:0.113550:0.076190:0.113550:0.006515:0.006515:0.003257:0.003257:0.005656:0.009560:0.007173:0.007150:0.003540:0.007608:0.007173:0.006362:0.005668:0.003257:0.006362:0.010807:0.008032:0.002352:0.003986:0.002352:0.008032:0.007173:0.008055:0.006362:0.006950:0.003257:0.006362:0.002658:0.007173:0.006515:0.008032:0.004563:0.002352:0.006515:0.007644:0.003257:0.003116:0.008020:0.008032:0.007608:0.003986:0.007644:0.003540:0.002352:0.008032:0.002352:0.006362:0.007608:0.007702:0.003904:0.002352:0.007173:0.003692:0.007644:0.007608:0.003986:0.002352:0.007702:0.007173:0.006362:0.002352:0.007173:0.006362:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.007173:0.003257
children with plasmodium falciparum malaria: a systematic review. :@0.101390:0.136727:0.484213:0.136727:0.484213:0.124451:0.101390:0.124451:0.007608:0.007173:0.002352:0.002352:0.008055:0.003540:0.007644:0.007173:0.003410:0.009772:0.002352:0.003986:0.007173:0.003410:0.006961:0.002352:0.008032:0.004563:0.011030:0.007702:0.008055:0.002352:0.007150:0.011030:0.003410:0.003692:0.008032:0.002352:0.007608:0.002352:0.008020:0.008032:0.003540:0.007150:0.011030:0.003422:0.011030:0.008032:0.002352:0.008032:0.003540:0.002352:0.008032:0.003257:0.003422:0.008032:0.003410:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003422:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
BMC Med. :@0.101390:0.147628:0.164785:0.147628:0.164785:0.135353:0.101390:0.135353:0.006750:0.010807:0.009560:0.003257:0.010807:0.007644:0.008055:0.003257:0.003257
2014;12:31-47:@0.164785:0.147628:0.240350:0.147628:0.240350:0.135353:0.164785:0.135353:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515
13.  Dellicour s, sevene E, McGready R, :@0.076190:0.158530:0.309282:0.158530:0.309282:0.146254:0.076190:0.146254:0.006515:0.006515:0.003257:0.003257:0.005656:0.008749:0.007644:0.002352:0.002352:0.002352:0.007608:0.007702:0.007150:0.003540:0.004280:0.005856:0.003257:0.004280:0.005856:0.007644:0.006515:0.007644:0.007173:0.007644:0.004280:0.006303:0.003257:0.004280:0.010807:0.007608:0.010254:0.003540:0.007644:0.008032:0.008055:0.006303:0.004280:0.007138:0.003257:0.003257
et al.:@0.310305:0.158530:0.339856:0.158530:0.339856:0.146254:0.310305:0.146254:0.007644:0.003986:0.004280:0.008032:0.002352:0.003257
 First-trimester artemisinin :@0.339856:0.158530:0.484189:0.158530:0.484189:0.146254:0.339856:0.146254:0.004280:0.005703:0.002352:0.003540:0.004563:0.003986:0.003904:0.003986:0.003540:0.002352:0.011030:0.007644:0.004563:0.003986:0.007644:0.003540:0.004269:0.008032:0.003540:0.003986:0.007644:0.011030:0.002352:0.004563:0.002352:0.007173:0.002352:0.007173:0.003257
derivatives and quinine treatments and the risk of adverse preg-:@0.101390:0.169431:0.480956:0.169431:0.480956:0.157156:0.101390:0.157156:0.008055:0.007644:0.003540:0.002352:0.006515:0.008032:0.003986:0.002352:0.006515:0.007644:0.004563:0.004986:0.008032:0.007173:0.008055:0.004986:0.008020:0.007150:0.002352:0.007173:0.002352:0.007173:0.007644:0.004986:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.004563:0.004974:0.008032:0.007173:0.008055:0.004986:0.003986:0.007173:0.007644:0.004974:0.003540:0.002352:0.004563:0.005903:0.004986:0.007702:0.003692:0.004974:0.008032:0.008055:0.006515:0.007644:0.003540:0.004563:0.007644:0.004986:0.008020:0.003540:0.007644:0.007914:0.003904
nancy outcomes in Africa and Asia: A meta-analysis of observa-:@0.101390:0.180333:0.480944:0.180333:0.480944:0.168057:0.101390:0.168057:0.007173:0.008032:0.007173:0.007608:0.006303:0.004915:0.007702:0.007150:0.003986:0.007608:0.007702:0.011030:0.007644:0.004563:0.004915:0.002352:0.007173:0.004927:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.004915:0.008032:0.007173:0.008055:0.004927:0.008702:0.004563:0.002352:0.008032:0.003257:0.004927:0.008702:0.004915:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.004927:0.007702:0.003692:0.004915:0.007702:0.008020:0.004563:0.007644:0.003540:0.006515:0.008032:0.003904
tional studies. :@0.101390:0.191234:0.181071:0.191234:0.181071:0.178959:0.101390:0.178959:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003257:0.004563:0.003986:0.007150:0.008055:0.002352:0.007644:0.004563:0.003257:0.003257
PLoS Med. :@0.181071:0.191234:0.243301:0.191234:0.243301:0.178959:0.181071:0.178959:0.006961:0.005433:0.007702:0.005856:0.003257:0.010807:0.007644:0.008055:0.003257:0.003257
2017;14: e1002290.:@0.243289:0.191234:0.348652:0.191234:0.348652:0.178959:0.243289:0.178959:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.003257:0.007644:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
14.  Chiodini pL, patel D, Whitty CJM, :@0.076190:0.202136:0.293125:0.202136:0.293125:0.189860:0.076190:0.189860:0.006515:0.006515:0.003257:0.003257:0.005656:0.009560:0.007173:0.002352:0.007702:0.008055:0.002352:0.007173:0.002352:0.004151:0.006961:0.005433:0.003257:0.004139:0.006961:0.008032:0.003986:0.007644:0.002352:0.004151:0.008749:0.003257:0.004151:0.011289:0.007173:0.002352:0.003986:0.003986:0.006303:0.004151:0.009560:0.005668:0.010807:0.003257:0.003257
et al.:@0.293995:0.202136:0.323405:0.202136:0.323405:0.189860:0.293995:0.189860:0.007644:0.003986:0.004139:0.008032:0.002352:0.003257
 Guidelines for malaria pre-:@0.323405:0.202136:0.480944:0.202136:0.480944:0.189860:0.323405:0.189860:0.004151:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.004151:0.003692:0.007702:0.003540:0.004139:0.011030:0.008032:0.002352:0.008032:0.003540:0.002352:0.008032:0.004151:0.008020:0.003540:0.007644:0.003904
vention in travellers from the United Kingdom, 2017. London: public :@0.101390:0.213037:0.484213:0.213037:0.484213:0.200762:0.101390:0.200762:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.003434:0.002352:0.007173:0.003445:0.003986:0.003540:0.008032:0.006515:0.007644:0.002352:0.002352:0.007644:0.003540:0.004563:0.003445:0.003692:0.003540:0.007702:0.011030:0.003434:0.003986:0.007173:0.007644:0.003434:0.007702:0.007173:0.002352:0.003986:0.007644:0.008055:0.003434:0.006950:0.002352:0.007173:0.007914:0.008055:0.007702:0.011030:0.003257:0.003434:0.006515:0.006515:0.006515:0.006515:0.003257:0.003445:0.005433:0.007702:0.007173:0.008055:0.007702:0.007173:0.003257:0.003457:0.006961:0.007150:0.008020:0.002352:0.002352:0.007608:0.003257
Health England; October 2017.:@0.101390:0.223938:0.276674:0.223938:0.276674:0.211663:0.101390:0.211663:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.003257:0.006303:0.007173:0.007914:0.002352:0.008032:0.007173:0.008055:0.003257:0.003257:0.010219:0.007608:0.003986:0.007702:0.008020:0.007644:0.003540:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
15.  Tan KR, Magill AJ, parise ME, :@0.076190:0.234840:0.264973:0.234840:0.264973:0.222565:0.076190:0.222565:0.006515:0.006515:0.003257:0.003257:0.005656:0.004892:0.007914:0.007056:0.004139:0.006832:0.007020:0.003140:0.004139:0.010689:0.007914:0.007796:0.002234:0.002234:0.002234:0.004139:0.008584:0.005550:0.003140:0.004139:0.006844:0.007914:0.003422:0.002234:0.004445:0.007526:0.004139:0.010689:0.006185:0.003140:0.003257
et al.:@0.265855:0.234840:0.294795:0.234840:0.294795:0.222565:0.265855:0.222565:0.007526:0.003869:0.004139:0.007914:0.002234:0.003257
 Doxycycline for malaria chemo-:@0.294677:0.234840:0.480979:0.234840:0.480979:0.222565:0.294677:0.222565:0.004139:0.008631:0.007585:0.005527:0.006185:0.007491:0.006185:0.007491:0.002234:0.002234:0.007056:0.007526:0.004139:0.003575:0.007585:0.003422:0.004139:0.010913:0.007914:0.002234:0.007914:0.003422:0.002234:0.007914:0.004139:0.007491:0.007056:0.007526:0.010913:0.007585:0.003904
prophylaxis and treatment: Report from the CDC expert meeting on :@0.101390:0.245741:0.484213:0.245741:0.484213:0.233466:0.101390:0.233466:0.007902:0.003422:0.007585:0.007902:0.007056:0.006185:0.002234:0.007914:0.005527:0.002234:0.004445:0.003210:0.007914:0.007056:0.007937:0.003210:0.003869:0.003422:0.007526:0.007914:0.003869:0.010913:0.007526:0.007056:0.003869:0.003140:0.003222:0.007020:0.007526:0.007902:0.007585:0.003422:0.003869:0.003222:0.003575:0.003422:0.007585:0.010913:0.003210:0.003869:0.007056:0.007526:0.003210:0.009443:0.008631:0.009443:0.003210:0.007526:0.005527:0.007902:0.007526:0.003422:0.003869:0.003210:0.010913:0.007526:0.007526:0.003869:0.002234:0.007056:0.007796:0.003210:0.007585:0.007173:0.003257
malaria chemoprophylaxis. :@0.101390:0.256643:0.256448:0.256643:0.256448:0.244367:0.101390:0.244367:0.010913:0.007914:0.002234:0.007914:0.003422:0.002234:0.007914:0.003140:0.007491:0.007056:0.007526:0.010913:0.007585:0.007902:0.003422:0.007585:0.007902:0.007056:0.006185:0.002234:0.007914:0.005527:0.002234:0.004445:0.003140:0.003257
Am J Trop Med Hyg. :@0.256330:0.256643:0.372182:0.256643:0.372182:0.244367:0.256330:0.244367:0.008584:0.010913:0.003140:0.005550:0.003140:0.004892:0.003422:0.007585:0.007902:0.003140:0.010689:0.007526:0.007937:0.003140:0.007914:0.006185:0.007796:0.003140:0.003257
2011;84(4),517-531:@0.372065:0.256643:0.473853:0.256643:0.473853:0.244367:0.372065:0.244367:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.006397:0.006515
16.  Tickell-painter M, Maayan N, saunders R, :@0.076190:0.267544:0.337493:0.267544:0.337493:0.255269:0.076190:0.255269:0.006515:0.006515:0.003257:0.003257:0.005656:0.005009:0.002352:0.007608:0.005903:0.007644:0.002352:0.002352:0.003904:0.006961:0.008032:0.002352:0.007173:0.003986:0.007644:0.003540:0.003845:0.010807:0.003257:0.003845:0.010807:0.008032:0.008032:0.006303:0.008032:0.007173:0.003845:0.008702:0.003257:0.003845:0.005856:0.008032:0.007150:0.007173:0.008055:0.007644:0.003540:0.004563:0.003845:0.007138:0.003257:0.003257
et al. :@0.338081:0.267544:0.370454:0.267544:0.370454:0.255269:0.338081:0.255269:0.007644:0.003986:0.003845:0.008032:0.002352:0.003257:0.003257
Mefloquine for pre:@0.371042:0.267544:0.477063:0.267544:0.477063:0.255269:0.371042:0.255269:0.010807:0.007644:0.002852:0.002852:0.007702:0.008020:0.007150:0.002352:0.007173:0.007644:0.003845:0.003692:0.007702:0.003540:0.003845:0.008020:0.003540:0.007644
-:@0.477063:0.267544:0.480967:0.267544:0.480967:0.255269:0.477063:0.255269:0.003904
venting malaria during travel to endemic areas. Cochrane Data-:@0.101390:0.278446:0.480956:0.278446:0.480956:0.266170:0.101390:0.266170:0.006515:0.007644:0.007173:0.003986:0.002352:0.007173:0.007914:0.004469:0.011030:0.008032:0.002352:0.008032:0.003540:0.002352:0.008032:0.004480:0.008055:0.007150:0.003540:0.002352:0.007173:0.007914:0.004469:0.003986:0.003540:0.008032:0.006515:0.007644:0.002352:0.004480:0.003986:0.007702:0.004469:0.007644:0.007173:0.008055:0.007644:0.011030:0.002352:0.007608:0.004480:0.008032:0.003540:0.007644:0.008032:0.004563:0.003257:0.004480:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.004469:0.008749:0.008032:0.003986:0.008032:0.003904
base of systematic Reviews. 2017; Issue 10. Art. No.: CD006491:@0.101390:0.289347:0.452580:0.289347:0.452580:0.277072:0.101390:0.277072:0.008020:0.008032:0.004563:0.007644:0.003257:0.007702:0.003692:0.003257:0.005856:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003257:0.007138:0.007644:0.006515:0.002352:0.007644:0.009772:0.004563:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.002658:0.004563:0.004563:0.007150:0.007644:0.003257:0.006515:0.006515:0.003257:0.003257:0.008702:0.003540:0.003986:0.003257:0.003257:0.008702:0.007702:0.003257:0.003257:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515
17.  HIV Drug Interactions.  University of Liverpool.  https://www.hiv-:@0.076190:0.300249:0.480956:0.300249:0.480956:0.287973:0.076190:0.287973:0.006515:0.006515:0.003257:0.003257:0.005656:0.008032:0.002658:0.008255:0.008631:0.008749:0.003540:0.007150:0.007914:0.008631:0.002658:0.007173:0.003986:0.007644:0.003540:0.008032:0.007608:0.003986:0.002352:0.007702:0.007173:0.004563:0.003257:0.003257:0.005362:0.007702:0.007173:0.002352:0.006515:0.007644:0.003540:0.004563:0.002352:0.003986:0.006303:0.008631:0.007702:0.003692:0.008631:0.005433:0.002352:0.006515:0.007644:0.003540:0.008020:0.007702:0.007702:0.002352:0.003257:0.003257:0.005374:0.007173:0.003986:0.003986:0.008020:0.004563:0.003257:0.005139:0.005139:0.009772:0.009772:0.009772:0.003257:0.007173:0.002352:0.006515:0.003904
druginteractions.org (accessed 20/01/2019):@0.101390:0.311150:0.349852:0.311150:0.349852:0.298875:0.101390:0.298875:0.008055:0.003540:0.007150:0.007914:0.002352:0.007173:0.003986:0.007644:0.003540:0.008032:0.007608:0.003986:0.002352:0.007702:0.007173:0.004563:0.003257:0.007702:0.003540:0.007890:0.003257:0.004339:0.008032:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.006515:0.006515:0.005139:0.006515:0.006515:0.005139:0.006515:0.006515:0.006515:0.006515:0.004339